Fennec Pharmaceuticals Inc. (FENC)

$6.94

-0.15 (-2.12%)
Rating:
Recommendation:
Buy
Symbol FENC
Price $6.94
Beta 0.090
Volume Avg. 0.03M
Market Cap 180.713M
Shares () -
52 Week Range 3.822-10.078
1y Target Est -
DCF Unlevered FENC DCF ->
DCF Levered FENC LDCF ->
ROE -217.00% Strong Sell
ROA -194.62% Strong Sell
Operating Margin -
Debt / Equity 82.27% Buy
P/E -
P/B 21.17 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest FENC news


Mr. Rostislav Raykov
Healthcare
Biotechnology
NASDAQ Capital Market

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.